How tirzepatide affects brain dopamine in people with alcohol use disorder
About this title
Read the official source — NCT07559500Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
What will I do during this study?
The study has two parts. In Part 1, five healthy volunteers have two or three PET/MRI (magnetic resonance imaging) visits two to three weeks apart, including tracer and methylphenidate procedures. In Part 2, participants are randomly assigned to tirzepatide or placebo (an inactive comparison treatment) and receive two injections one week apart, with PET and functional MRI assessments. These parts involve different participant groups and procedures.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 176
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT07559500
- Official title
Show the full official title
Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD), a Phase 1b Study
Recruitment & locations
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.
Does this study involve medication?
Yes. The study involves medication, including Tirzepatide, Placebo, [11C]raclopride plus drug and [11C]NNC-112.
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
